Previous 10 | Next 10 |
Gainers: Intra-Cellular Therapies (NASDAQ: ITCI ) +204% . More news on: Intra-Cellular Therapies, Inc., Cassava Sciences, Inc., Microbot Medical Inc., Stocks on the move, Read more ...
Intra-Cellular Therapies (NASDAQ: ITCI ) +89% after Caplyta approved by FDA. More news on: Intra-Cellular Therapies, Inc., Cincinnati Bell Inc., Seadrill Limited, Stocks on the move, Read more ...
Microbot Medical (NASDAQ: MBOT ) +6.1% pre-market after unveiling what it says is the world's first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular procedures. More news on: Microbot Medical Inc., Healthcare stocks news, Stocks on t...
Live Demonstration Planned for Monday, January 13, 2020, in San Francisco Breakthrough technology features compact design, remote operation capabilities and an integrated “One & Done” tool to democratize endovascular procedures HINGHAM, Mass., Dec. 23, 2019 (GLO...
Gainers: Camber Energy (NYSEMKT: CEI ) +130% . More news on: Camber Energy, Inc., Marinus Pharmaceuticals, Inc., Centogene N.V., Stocks on the move, Read more ...
HINGHAM, Mass., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Further demonstrating its commitment to expand and protect its Intellectual Property (IP) portfolio, Microbot Medical Inc. (Nasdaq: MBOT) was issued a Notice of Allowance for patent application No. 15/936,878 by the U.S. Patent and Trademark...
HINGHAM, Mass., Oct. 30, 2019 (GLOBE NEWSWIRE) -- In an expansion of its significant global patent estate, Microbot Medical Inc. (Nasdaq: MBOT) announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No. 15/218,025, covering the Co...
Gainers: PDS Biotechnology (NASDAQ: PDSB ) +23% . The Meet Group (NASDAQ: MEET ) +20% . Synthesis Energy Systems (NASDAQ: SES ) +14% . Microbot Medical (NASDAQ: MBOT ) +19% . TuanChe (NASDAQ: TC ) +14% . Arcturus Therapeutics Holdings (NASDAQ: ARCT ) +14% . Sorrento Therapeutics (NA...
Robotic-Assisted Surgery on the Rise In earlier articles, we have discussed how the medical robotics sector has strong growth prospects. Robotic surgery currently accounts for less than 10% of total surgeries, according to TransEnterix (NYSEMKT: TRXC ), with "continued expansion into addit...
Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS TM ) HINGHAM, Mass., Sept. 13, 2019 (GLOBE NEWSWIRE) -- Having successfully executed a number of significant milestones over the past twelve months, Microbot Medical Inc. (NASDAQ: MBOT) held its 2019...
News, Short Squeeze, Breakout and More Instantly...
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
BRAINTREE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board (IRB) approval and signed a clinical trial agreement with Memor...
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular R...
The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular Robotic Surgical System BRAINTREE, Mass., July 08, 2024 (G...